News
-
Swissmedic: Mandatory SEND dataset submission for new active substance authorisation applications
-
FOPH: Increased reimbursement for specialised palliative care under the Health Insurance Act (HIA)
-
FOPH: Launch of NASURE digital surveillance platform for communicable diseases
-
FOPH: Health Insurance Benefits Ordinance amendments to deliver CHF 92 Million in annual savings and expand vaccination access
-
Decision 8C_8/2026 of 8 June 2026 (designated for publication)
-
FOPH: Insurers Authorised to Proactively Inform Insured Persons of Cost-Efficient Options
-
Decision 9C_280/2025 and 9C_286/2025 of 2 June 2026
-
Swissmedic: Updated guidelines for quality assurance in transfusion practice
-
Swissmedic: Changes to the Project Orbis guidance document
-
Swissmedic: Federal contribution to the Swiss Agency for Therapeutic Products Swissmedic to be increased
-
Decision 9C_623/2025 of 27 May 2026
-
FOPH: Report on cantonal cost-equalisation funds under the Health Insurance Act (HIA)
-
FOPH: Federal Council Mandates Legislation to Integrate Advanced Nurse Practitioner (ANP) into Mandatory Health Insurance
-
European Medicines Agency: EU Tracks Progress Towards 2030 Clinical Trial Targets
-
Decision 2C_177/2026 of 18 May 2026
-
Judgment of the Court of Justice of the European Union in the Case C 483/24 of 13 May 2026
-
European Medicines Agency: Welcomes Political Agreement on Critical Medicines Act
-
Swissmedic: Compliant Implementation of Clinical Trials of Medicinal Products and ATMPs with Multiple Sponsors
-
Swissmedic: Summary Report on Authorization of Bimzelx®
-
FOPH: Switzerland to introduce Electronic Health Dossier as part of digital health overhaul
-
Swissmedic: Swissmedic Vigilance-News Edition 36